An apparatus and method of the invention provide for the measurement of sensory or motor nerve conduction parameters with automatic setting of stimulus intensity. An apparatus of the invention includes a stimulator for stimulating a nerve, a detector for detecting an evoked signal generated by the nerve or a muscle innervated by the nerve, and a controller for determining a stimulus intensity for use in conducting the measurements in response to the stimulation and evoked signal. Methods of the invention include stimulating a nerve, detecting an evoked signal generated by the nerve or by a muscle innervated by the nerve in response to the stimulation, and determining a stimulus intensity for use in conducting sensory or motor nerve conduction in response to the stimulation and evoked signal. In determining the stimulus intensity level, the nerve is stimulated at incrementally increasing stimulus intensities, and the respective evoked signals are detected. A parameter that quantifies the magnitude of each evoked signal is then determined, and the parameters of two consecutive evoked signals are compared until the parameter of one of the evoked signals is greater than a predetermined fraction of the parameter of an immediately succeeding evoked signal.

Patent
   6266558
Priority
Dec 01 1998
Filed
Dec 01 1998
Issued
Jul 24 2001
Expiry
Dec 01 2018
Assg.orig
Entity
Small
421
12
all paid
16. A method for measuring sensory or motor nerve conduction with automatic setting of stimulus intensity, comprising the steps of:
(a) stimulating a nerve;
(b) detecting an evoked signal generated by said nerve or by a muscle innervated by said nerve in response to said stimulation;
(c) automatically determining an operable stimulus intensity in response to said stimulation and said evoked signal;
(d) conducting said sensory or motor nerve conduction measurements using said operable stimulus intensity;
(e) repeating steps (a) and (b) at incrementally increasing stimulus intensities;
(f) determining a parameter which quantifies a magnitude of said response signal; and
(g) comparing said parameters of two sequential evoked signals until said parameter of one of said evoked signals is greater than a predetermined fraction of said parameter of an immediately succeeding evoked signal.
1. An apparatus for measuring sensory and motor nerve conduction with automatic setting of stimulus intensity, comprising:
(a) a stimulator capable of producing a stimulus and for applying said stimulus to a nerve;
(b) a detector capable of detecting at least two sequential evoked signals from said nerve or from a muscle innervated by said nerve in response to said stimulus; and
(c) a controller for automatically determining an operable stimulus intensity at which to measure nerve conduction in response to said stimulus and said evoked signal and for directing said stimulator to stimulate said nerve at said operable stimulus intensity, said controller comprising a comparator for comparing said at least two sequential evoked signals until one evoked signal is greater than a predetermined faction of an immediately succeeding evoked signal,
whereby nerve conduction is then measured using said operable stimulus intensity.
2. The apparatus of claim 1, wherein said operable stimulus intensity is selected from the group consisting of a maximal stimulus intensity and a near maximal stimulus intensity.
3. The apparatus of claim 1, wherein said controller is further for determining a nerve conduction measurement in response to said evoked signal and for producing a controller signal indicative of said nerve conduction measurement.
4. The apparatus of claim 3, further comprising a display in electrical communication with said controller and for receiving said controller signal and for indicating said sensory or motor nerve conduction measurements in response to said controller signal.
5. The apparatus of claim 4, wherein said display is a liquid crystal display.
6. The apparatus of claim 1, wherein said stimulus is selected from the group consisting of an electrical stimulus, a magnetic stimulus, and an optical stimulus.
7. The apparatus of claim 1, further comprising an external interface for establishing communication between said controller and an external device, whereby said external device is adapted for evaluating and for indicating said nerve conduction measurements in response to said evoked signal.
8. The apparatus of claim 1, further comprising a converter for converting electrical stimuli produced by said stimulator into bioelectrical signals for stimulation of a nerve.
9. The apparatus of claim 8, wherein said converter is further for converting bioelectrical signals generated by a nerve into electrical signals for detection by said detector.
10. The apparatus of claim 1, wherein said controller comprises a main controller and a stimulator controller.
11. The apparatus of claim 10, wherein said main controller is for determining said operable stimulus intensity and for generating a stimulus signal indicative of said operable stimulus intensity.
12. The apparatus of claim 11, wherein said stimulator controller is in electrical communication with said main controller and is for receiving said stimulus signal and for directing said stimulator to stimulate said nerve at said operable stimulus intensity.
13. The apparatus of claim 1, further comprising a temperature sensor for measuring the temperature of skin adjacent said nerve or muscle innervated by said nerve.
14. The apparatus of claim 13, wherein said controller is further for adjusting said sensory or motor nerve conduction measurement in response to said measured temperature.
15. The method of claim 14, wherein said operable stimulus intensity is selected from the group consisting of a maximal stimulus intensity and a near maximal stimulus intensity.
17. The method of claim 16, wherein said parameter is selected from the group consisting of a peak of a first derivative of said evoked signal, a peak of a second derivative of said evoked signal, and an amplitude of said evoked signal.
18. The method of claim 16, further comprising the step of measuring a temperature of skin adjacent said nerve or muscle innervated by said nerve.
19. The method of claim 18, further comprising the step of adjusting said parameter in response to said measured temperature.
20. The method of claim 16, further comprising the step of indicating said sensory or motor nerve conduction measurements.

The invention relates to an apparatus and method for measuring nerve conduction. More particularly, the invention relates to an apparatus and method for measuring nerve conduction which automatically sets the intensity of the stimulus used to conduct such measurements.

Pathologies of the peripheral nerves and muscles are common clinical conditions. Carpal Tunnel Syndrome and diabetic neuropathy affect ten million individuals in the U.S. alone. Because they are so common, disease detection and early management are often the responsibility of general practitioners, such as primary care or family physicians, occupational physicians, and endocrinologist. These conditions are, however, difficult to diagnose and evaluate using only the clinical history and physical symptoms. The only objective way to investigate peripheral nerve disease is to measure nerve conduction parameters that quantify the transmission of neural signals between two points on a nerve or between a point on a nerve and a muscle innervated by that nerve. The gold standard approach is a formal nerve conduction study by a clinical neurologist. This diagnostic test, however, has a number of important disadvantages. First, it is time consuming and requires the services of a medical expert, such as a neurologist. Second, it is costly (e.g., typically $600-$1000). Third, it is generally not available in point-of-care environments where early detection and management would be expected to have the greatest potential impact on morbidity and medical costs.

As a result of these disadvantages, formal nerve conduction studies are used in a relatively restricted fashion. They are most often employed to confirm a diagnosis prior to a significant intervention, such as surgery. The potential clinical uses of nerve conduction information, however, go well beyond these limited applications into pointof-care testing for confirmation of clinical diagnoses, as well as into intensive monitoring to detect objective evidence of response to therapeutic interventions, such as pharmacological agents and physical therapy. Peripheral nerve diagnostics that are appropriate for point-of-care environments and that are easier-to-use and less-costly are, therefore, needed.

A nerve conduction measurement typically occurs by stimulating a nerve with a short electrical impulse and then measuring the evoked response along the same nerve at a second location for a sensory or mixed nerve measurement, or over a muscle innverated by the stimulated nerve for a motor nerve measurement. Nerve conduction is most often characterized by either the latency or the conduction velocity (determined from latency and distance between stimulation and detection sites) of the evoked response. The amplitude of evoked response is also used, but to a lesser degree. The accuracy and reliability of the nerve conduction measurement is dependent on a number of technical factors. One such factor is the magnitude of the electrical stimulus used to evoke the response. In particular, the intensity of the electrical stimulus must be set within a fairly narrow range. Identifying this range is complicated by the fact that its value varies from person to person, nerve to nerve, and even from time to time in a specific nerve in an individual.

The low end of the stimulus intensity range is defined by the fact that the nerve must be stimulated at an intensity for which additional increases in stimulus intensity do not lead to further increases in the amplitude of the evoked response. This response saturation effect results from the complete activation of all the large and fast conducting myelinated nerve fibers at a stimulus intensity called the maximal stimulus intensity. Further increases in intensity may activate smaller and slower conducting fibers, but these fibers do not contribute to the early portion of the nerve response from which most traditional nerve conduction parameters are measured. Because sub-maximal stimuli do not activate the fastest conducting nerve fibers, the measured nerve conduction parameters may appear artificially slow and small, thus mimicking nerve pathology. Stimulus intensities above this maximal stimulus intensity are called supramaximal. A "near maximal" stimulus intensity (e.g., within 10-20% of maximal) is sufficient for accurate and reliable latency and conduction velocity measurements. Amplitude measurements, however, still require use of a maximal or supramaximal stimulus intensity. Although the prior art reveals a number of attempts to simplify and automate the assessment of peripheral nerve physiology, it has failed to automate and optimize the process of establishing the ideal stimulus intensity for measuring the evoked response.

The stimulus intensity is limited at the high end by a number of measurement errors and patient issues that result from overly elevated stimulus intensities. First, high stimulus intensities may lead to a "virtual cathode" effect in which the apparent point of stimulation on the nerve shifts away from the actual site of the stimulating electrode. This may lead to an artificial increase in the nerve conduction velocity or, equivalently, a decrease in the nerve conduction latency. Second, high stimulus intensities may accidentally coactivate nerves that are anatomically adjacent to the intended nerve. This can severely distort the detected signals, particularly with motor nerve measurements in which the coactivated nerve innervates muscles in the vicinity of those innervated by the intended nerve. In extreme cases, the stimulus may directly activate muscles, thereby completely bypassing the peripheral nerve and yielding incorrect nerve conduction measurement values. Third, patient discomfort is generally related to stimulus intensity. Very high stimulus intensity can cause a significant amount of discomfort and even pain.

There remains, therefore, a need for apparatus and methods for assessing peripheral nerve physiology that are easy to use, rapid and automatic. Futhermore, in order to generate accurate and reliable nerve conduction parameters, these apparatus and methods must determine the lowest possible stimulus intensity that provides a maximal or near maximal evoked response. Such apparatus and methods are needed to provide more widespread early detection, prevention, and monitoring of peripheral nerve disease. The present invention addresses these needs.

The apparatus and method of the present invention provide for nerve conduction measurements with the automatic setting of stimulus intensity. An apparatus of the invention includes a stimulator for producing a stimulus and applying that stimulus to a nerve, and a detector for detecting an evoked signal generated by the nerve, or by a muscle innervated by the nerve, in response to the stimulation. In one embodiment, the nerve is a peripheral nerve. The stimulus generated by the stimulator includes, but is not limited to, an electrical, magnetic, or optical stimulus.

An apparatus of the invention further includes a controller for determining an operable stimulus intensity at which to measure sensory or motor nerve conduction and for directing the stimulator to stimulate the nerve at this operable stimulus intensity. The operable stimulus intensity may be the maximal stimulus intensity or the near maximal stimulus intensity. The controller may also determine the nerve conduction measurements and may generate a controller signal indicative of these measurements. A controller for use in the invention may be embodied as two separate controllers, which include both a main controller and a stimulator controller. When the invention is embodied with both a main controller and a stimulator controller, the main controller is for determining an operable stimulus intensity and for generating a stimulus signal, which is indicative of this operable stimulus intensity. The stimulator controller is in electrical communication with the main controller and is adapted for receiving the stimulus signal and for directing the stimulator to stimulate the nerve in response to this signal.

In other embodiments of the invention, an apparatus includes a display, which may be a liquid crystal display. In one embodiment, the display is adapted for receiving the controller signal from the controller and for indicating the nerve conduction measurements in response to that signal.

In another embodiment, an apparatus of the invention has an external interface for establishing communication between the controller and an external device. In one embodiment, the external device is a personal computer and is adapted for evaluating and indicating nerve conduction measurements in response to the response signal.

Finally, in another embodiment, an apparatus of the invention includes a converter for converting electrical stimuli produced by the stimulator into bioelectrical signals for stimulation of a nerve. A converter is also adapted for converting bioelectrical signals generated by a nerve into electrical signals for detection by the detector.

A method of the invention includes measuring sensory or motor nerve conduction by stimulating a nerve, which is preferably a peripheral nerve, detecting an evoked signal generated by that nerve or a muscle innervated by that nerve in response to the stimulation, determining an operable stimulus intensity in response to the stimulation and the evoked signal, and conducting sensory or motor nerve conduction measurements using the operable stimulus intensity so determined. The operable stimulus intensity may be either the maximal or the near maximal stimulus intensity for the nerve.

The step of determining the operable stimulus intensity includes three other steps: (1) the step of repeatedly stimulating the nerve at incrementally increasing stimulus intensities and detecting the evoked signals generated by the nerve at each of these stimulus intensities; (2) the step of determining a parameter which quantifies a magnitude of the evoked signal for each of the stimulus intensities; and (3) the step of comparing the parameters of two consecutive evoked signals until the parameter of one of the evoked signals is greater than a predetermined fraction of the parameter of an immediately succeeding evoked signal. The parameter quantifying the magnitude of the response may include a peak of a first derivative of the evoked signal, a peak of a second derivative of the evoked signal, and an amplitude of the evoked signal.

In one embodiment, the method of the invention includes the step of measuring a temperature of skin adjacent the nerve or muscle innervated by the nerve. These temperature measurements may then be used to adjust the parameters of the evoked signals relative to the temperature measurements. Finally, in another embodiment, the method of the invention includes the step of indicating the sensory or motor nerve conduction measurements.

Apparatus and method of the invention therefore provide for the measurement of sensory and motor nerve conduction with automatic setting of maximal or near maximal stimulus intensities. The invention therefore provides for sensory or motor nerve conduction measurements without the use of a medical expert, without the high cost of traditional measurements, and without significant discomfort to the patient.

Apparatus and methods of the invention will be understood further upon consideration of the following drawings, description, and claims.

FIG. 1 shows the non-linear relationship between the stimulus intensity and the amplitude of the evoked response in a peripheral nerve.

FIG. 2 is a block diagram of an embodiment of an apparatus of the invention.

FIG. 3 is a flow chart of a method for establishing a maximal or near maximal stimulus intensity.

FIGS. 4A and 4B shows a series of responses evoked by a median nerve that is stimulated using an apparatus and method of the invention.

An apparatus and method are provided for automatically determining the intensity of a stimulus to be applied to a peripheral nerve in the course of performing a nerve conduction measurement. In various embodiments, the stimulus is an electrical, magnetic or optical stimulus, but is preferably an electrical stimulus. Because the invention utilizes a model of the peripheral nerve stimulus-response relationship, it can automatically and optimally identify an operable stimulus intensity. An operable stimulus intensity includes a stimulus intensity at which sensory or motor nerve conduction measurements may be taken without significant discomfort to the patient/user. An operable stimulus intensity includes a near maximal stimulus intensity and a maximal stimulus intensity. As previously described, a maximal stimulus intensity is a stimulus intensity above which increases in stimulus intensity do not lead to further increases in the amplitude of the evoked response. The invention provides apparatus and methods to determine and control the stimulus intensity so as to ensure that the final stimulus intensity is greater than a fraction of the maximum obtainable response of the stimulated nerve. This final stimulus intensity is preferably within about 10% to about 20% of the maximal stimulus intensity and is called the near maximal stimulus intensity. Thus, the present invention has the substantial advantage that it will provide consistent and repeatable nerve conduction measurements that may be determined automatically and rapidly without involvement of the operator. Furthermore, because the stimulus intensity is set automatically, the method will exhibit improved reliability over the prior art.

The present invention has the further advantage that the automatically determined stimulus intensity is the smallest intensity that provides a near maximal response amplitude. This advantage reduces the probability of a number of technical errors that can decrease the accuracy and reliability of nerve conduction measurements. These errors include the "virtual cathode" effect, direct muscle stimulation and coactivation of anatomically adjacent nerves. This advantage also reduces patient discomfort associated with electrical stimulation.

Referring to FIG. 1, peripheral nerves exhibit a non-linear relationship, as shown by stimulus-response curve 10, between stimulus intensity 12 and the amplitude of the evoked response 14. This particular stimulus-response curve 10 was obtained by stimulating the median nerve at the wrist with constant current pulses and detecting the evoked myoelectrical response from the thenar muscles. Thus, FIG. 1 shows the stimulus-response curve 10 for the median motor nerve. The horizontal axis 12 indicates the intensity of the electrical stimulus in milliamps, and the vertical axis 14 shows the peak amplitude in millivolts of the evoked myoelectrical response.

At very low stimulus intensities 16, the stimulus is below the threshold for activation of the fast conducting myelinated nerve fibers, and there is, therefore, little, if any, muscle response. Consequently, at these levels the stimulus-response curve 10 changes little with increasing intensity and is essentially flat. At intermediate intensities 18, the stimulus progressively exceeds the threshold for activation of increasing numbers of fast conducting myelinated nerve fibers. This causes the stimulus-response curve 10 to change sharply and in a nearly linear fashion with intensity. Finally, at high stimulus intensity levels 20, the stimulus-response curve 10 again changes little with increasing intensity, because essentially all the fast conducting myelinated nerve fibers are above threshold and are contributing to the detected muscle response. As previously described, this latter stimulus intensity region is called the maximal or supramaximal region, because the response is at its maximal level despite continued increases in stimulus intensity. The stimulus-response relationship 10 demonstrated in FIG. 1 is characteristic of all peripheral nerves, but the stimulus intensity defining the midpoint 22 of the curve and the slope 24 of the curve varies from subject to subject, nerve to nerve, and even from time to time in the same nerve and subject.

As described previously, it is advantageous to automate the process of finding the maximal stimulus intensity. In the present invention this is accomplished by utilizing knowledge of the physiology of the nerve, particularly the non-linear stimulus-response relationship 10, as shown in FIG. 1.

An illustrative block diagram of an apparatus of the invention is shown in FIG. 2. Stimulator 26 generates a stimulus, and preferably generates an electrical stimulus. Unlike the prior art, the parameters of the stimuli are not determined by user actuated controls 28, but rather by control signals from stimulator controller 30, which is in electrical communication with stimulator 26. In a preferred embodiment, stimulator controller 30 is a single, integrated, low-cost embedded microcontroller. In a preferred embodiment, the stimuli are electrical stimuli of constant current pulses with amplitude and duration controlled by digital signals from stimulator controller 30. Other embodiments include electrical stimuli of constant voltage pulses or arbitrary waveforms. Stimulator 26 delivers stimuli to a peripheral nerve 32 through converter 34. Converter 34 includes a bioelectrical interface or any other means to convert electronic signals into bioelectrical signals that pass through the skin surface. In a preferred embodiment, converter 34 is a conventional silver/silver-chloride biomedical electrode located on the skin surface and is in electrical communication with stimulator 26.

Detector 36 detects biopotentials generated by a nerve or muscle 38. In a preferred embodiment, detector 36 is a high input impedance, high common mode rejection instrumentation amplifier followed by signal conditioning circuitry that amplify and filter biopotentials prior to digitization of the signals by main controller 40. Detector 36 also performs variable gain amplification of the detected biopotentials. Gain control is established by digital signals 27 from main controller 40. Detector 36 detects the biopotentials through a converter 34'. Converter 34' converts bioelectrical signals at the skin surface into electronic signals. In a preferred embodiment, converter 34' is a conventional silver/silver-chloride biomedical electrode located on the skin surface and in electrical communication with detector 36.

The output of detector 36 is in electrical communication 29 with the input of main controller 40, which digitizes, processes, and stores the waveforms acquired by the detector 36. In one embodiment, main controller 40 analyzes the waveforms. The parameters extracted from the waveforms include, but are not limited to, the peak amplitude of the waveform, the delay between the onset of the stimulus and the onset of the waveform, and the delay between the onset of the stimulus and the peak of the waveform. In one embodiment, main controller 40 also calculates and processes first and second derivatives of detected waveforms prior to extraction of the above-listed parameters. In one embodiment of the invention, the apparatus also includes a temperature sensor for measuring the temperature of the surface of the skin that is above the nerve or muscle innervated by the nerve from which conduction measurements are being taken. In this embodiment, the temperature sensor is in electrical communication with main controller 40, which adjusts the parameters described above in response to the skin temperature.

Main controller 40 is preferably embodied as a single, integrated, low-cost embedded microcontroller. In other embodiments, main controller 40 has multiple components, such as, for example, a microprocessor and external components that perform analog-to-digital conversion and other necessary functions.

User interface 28 allows the operator to interact with the apparatus. User interface 28 is in electrical communication with main controller 40. In a preferred embodiment, user interface 28 includes momentary pushbutton switches. Display 42 is also in electrical communication with main controller 40 and provides visual feedback to the operator regarding the results of the nerve conduction measurement or provides messages should measurement errors occur. In a preferred embodiment, display 42 is a liquid crystal display. Finally, external interface 44 communicates with external devices, such as a personal computer or a modem, for example. The external interface 44 is preferably in electrical communication with main controller 40 and is preferably embodied as an infra-red serial communication link. The external interface 44 is used to couple with external devices for evaluating nerve conduction parameters and for indicating those parameters to a user.

Main controller 40 is in electrical communication with stimulator controller 30 through isolator 46. In a preferred embodiment, isolator 46 is an optical isolator. Main controller 40 communicates with stimulator controller 30 in a master/slave relationship. Although the preferred embodiment utilizes a main controller 40 and a stimulator controller 30, other embodiments in which only a single controller is used have been contemplated.

In accordance with a preferred embodiment of the present invention, FIG. 3 shows an illustrative method for determining the maximal stimulus intensity automatically. The method commences in process step 48 by setting the stimulus intensity to a predetermined initial level, stiminit. This initial stimulus intensity is empirically chosen to be below the expected threshold for evoking a detectable response in the majority of individuals. The stimulus intensity is preferably within the range of about 0 mA to about 10 mA, and is more preferably within the range of about 2 mA to about 6 mA. For example, when stimulating the median nerve at the wrist and detecting the evoked myoelectrical response from the thenar muscles, stiminit is set at about 5 mA for about 200 μs. In addition, as shown in FIG. 3, a stimulus counter, count, is initialized to one in process step 48.

In process step 52, the target nerve is stimulated with an electrical pulse having the currently established intensity (e.g., stiminit if a first stimulus). Immediately thereafter, in process step 54, the bioelectrical response evoked by said stimulus is detected. Subsequently, in process step 56, a parameter (peakcount) quantifying the magnitude of the response is automatically determined. In the illustrative method, the peak of the first derivative of the evoked response is used for the parameter peakcount. In other embodiments, other parameters, such as the peak of the second derivative or the amplitude of the evoked response or the amplitude of the evoked response, is used in process step 56. Furthermore, in other embodiments, parameters obtained from averaging responses evoked by multiple stimuli may be used in process step 56.

In a preferred embodiment, the peak of the first derivative is obtained in process step 53 by first smoothing the evoked response, such as, for example, by convolving it with a smoothing function. Subsequently, the first derivative is calculated in process step 55 by estimating the instantaneous slope for each data point in the detected evoked response. The smoothing and first derivative operations can be combined and applied to small sections of the response curve and the values discarded if they do not indicate the presence of a peak in the first derivative. To avoid detection of spurious signals, such as those related to a stimulus artifact, the peak of the first derivative is evaluated within a defined time window in process step 56. This time window is defined as occurring within two time limits, t1 and t2. In a preferred embodiment, the lower time limit (t1) is predetermined and reflects the amount of time required for artifacts associated with the stimulus to decay to an amplitude that is significantly less than the amplitude of the actual evoked response signal. The lower time limit (t1) is preferably within the range of about 1.0 ms to about 2.5 ms. The lower time limit (t1) is more preferably about 2 ms. Other lower time limits may, however, be used. In addition, it is possible to dynamically establish the lower time limit (t1) by analyzing the amplitude decay of the stimulus associated artifact. In a preferred embodiment, the upper time limit (t2) is predetermined and must be larger than the longest delay expected before the onset of the evoked response. Both the upper (t2) and lower (t1) time limits are determined empirically through routine testing commonly know to those of ordinary skill in the art. The actual value of the upper time limit (t2) depends on the specific peripheral nerve being tested as well as the distance between the stimulation and detection sites.

Use of the peak of the first derivative to track changes in the amplitude of the response is advantageous, because the first derivative is considerably less affected by the stimulus artifact and other sources of baseline variation than is the actual evoked response. Furthermore, since the first derivative is a linear function of the actual response, the peak of the first derivative increases with the peak of the evoked response itself. Nevertheless, embodiments in which the peak of the response is used have been contemplated, as well as embodiments in which the peak of the second derivative or amplitude of the evoked response is used.

In process step 56, the first derivative of the response signal is measured with the assumption that the signal represents a viable evoked myoelectrical response. Referring again to FIG. 1, if the stimulus intensity is in the subthreshold region 16 of the stimulus-response curve, such a signal should not occur. Thus it is essential to validate that an actual nerve or muscle response was in fact obtained, which would imply that the stimulus intensity is in either the linear 18 or maximal 20 region of the stimulus-response curve.

In a preferred embodiment, this is accomplished in process step 58, by comparing the peak of the first derivative of the evoked response (peakcount) against a predetermined threshold peakmin) If the first derivative peak exceeds the threshold, the method assumes that a viable evoked response was obtained and continues to process step 60. On the other hand, if the first derivative peak falls below the threshold, the method proceeds to process step 62.

This predetermined threshold is obtained by processing biopotential signals detected by detector 36 of FIG. 2 in the absence of stimulation by stimulator 26 of FIG. 2. Under these conditions, the acquired signal represents noise sources only. The distribution of the first derivative of this "noise only signal" is determined. Based on this distribution, a threshold is chosen (i e., peakmin) that will have a very low probability of being exceeded by a signal consisting only of noise. In a preferred embodiment, a threshold that is three standard deviations above the mean is chosen (i.e., less than 2.5% of signals containing only noise will exceed this value). Thus, an evoked response signal with a peak first derivative that exceeds this threshold is expected to represent an actual evoked response signal rather than noise.

There are other methods of accomplishing the objective of process step 58 (i.e., of determining that the detected response represents a viable myoelectrical signal). In one such additional embodiment, a neural network that has been trained, such as by back propagation, to differentiate noise or stimulus artifacts from actual myoelectrical signals is applied to the detected signals. In another embodiment, more elaborate waveform features than the peak of the first derivative are utilized. For example, the difference between the positive and negative first derivative peaks has been contemplated. In yet another embodiment, matched filters that are tuned to the power spectral characteristics of evoked myoelectrical signals are utilized.

In process step 60 the amplitudes of the responses (peakcount-1 and peakcount) evoked by the last two stimulus intensities are compared. If the amplitude of the response evoked by the previous stimulus (peakcount-1) is larger than a predetermined fraction (f) of the amplitude of the response evoked by the current stimulus (peakcount), then according to the non-linear stimulus-response relationship 10 of FIG. 1, the stimulus intensity must be in the maximal region 20. The method for determining (ƒ) for a preferred embodiment of the invention is outlined below. If the predetermined fraction (ƒ) is less than 1, the method has identified a near maximal stimulus intensity. If the predetermined fraction is greater or equal to 1, the method has identified a maximal or supramaximal stimulus intensity. The predetermined fraction (ƒ) is preferably within the range of about 0.7 to about 1.1 and is more preferably within the range of about 0.8 to about 0.95. Measurements of the amplitudes may be affected by skin temperature, so another embodiment of the invention includes the step of measuring skin temperature adjacent the nerve or muscle innervated by the nerve and adjusting the amplitude in response to that temperature. Upon finding the maximal or near maximal stimulus intensity, the method proceeds to process step 64, where nerve conduction measurements are made.

In a preferred embodiment, the near maximal value of the fraction is determined empirically by analyzing stimulus-response curves obtained from a broad population of individuals in order to determine which fraction clearly identifies an evoked response that is consistently within 85% of the maximal possible response. (The 85% level was shown to be near maximal in Hodes, et al., "Low Threshold Associated with Slow Conduction Velocity," 12 Arch. Neurol. 510-526 (1965).) This was accomplished by setting the value off to 1.0, which forced the algorithm to achieve a maximal or supramaximal level. The resulting stimulus-response curves were then analyzed to determine which value off would have yielded a response within 85% of the maximal response. Based on these experiments, it was determined that a value of ƒ=0.90 would consistently yield such an evoked response. In the preferred embodiment, this value off was therefore chosen.

If the inequality tested in process step 60 is false, the current stimulus intensity is not in the maximal region of the stimulus-response curve 10 of FIG. 1. The method of FIG. 3 then proceeds to process step 66. In this step, the total number of stimuli that have been delivered is compared against a predetermined maximum number of stimuli (maxreps). The value of maxreps is preferably less than about 30. If the number of stimuli exceeds this predetermined limit, the method proceeds to process step 68. If the number of stimuli does not exceed the predetermined limit, however, the method proceeds to process step 62 where the stimulus intensity is increased. In a preferred embodiment, the stimulus intensity is increased by a predetermined amount (Δ) that is based on empirical experience. This amount (Δ) is preferably within the range of about 0 mA to about 20 mA and is more preferably within the range of about 0 mA to about 2.5 mA. This amount (Δ) is determined empirically through routine testing commonly known to those of ordinary skill in the art. Other embodiments have, however, been contemplated in which the stimulus is increased by a variable amount, such as, for example, in relation to the difference in the amplitude of the responses (peakcount -peakcount-1) evoked by the last two stimuli. In yet another embodiment, the stimulus intensity is increased according to a lookup table stored in either main controller 40 or stimulator controller 30 of FIG. 2. After increasing the stimulus intensity, the method returns to process step 52.

Process step 68 is reached if the inequality tested in process step 66 is true. In this case, a maximal or near maximal stimulus intensity could not be determined within the redetermined number of stimuli (maxreps). Since nerve conduction measurements require a maximal or near maximal stimulus intensity, the method reports that such an intensity could not be achieved and does not proceed to acquire further nerve responses for diagnostic purposes.

Process step 64 is reached if the inequality tested in process step 60 is true. As described above, the implication of satisfying this inequality is that the stimulus intensity must be in the maximal region 20 of the stimulus-response relationship 10 of FIG. 1. In step 64, the nerve is therefore stimulated with either the current or immediately preceding stimulus intensity, since both reside within the maximal region 20 of the stimulusresponse relationship 10, as shown in FIG. 1. A preferred embodiment may use the preceding stimulus intensity, because it is more moderate and, thus, less likely to cause discomfort to the patient. The responses evoked by stimuli with the given stimulus intensity are then analyzed, and nerve conduction parameters are extracted and utilized for diagnostic purposes.

FIGS. 4A and 4B show several bioelectrical responses evoked by a preferred embodiment of the invention in the course of automatically determining a near maximal stimulus intensity. These responses were obtained by stimulating the median nerve at the wrist and detecting the evoked myoelectrical response from the thenar muscles. FIG. 4A shows the evoked bioelectrical response as a function of time, and FIG. 4B shows the first derivative of the evoked response as a function of time. In both FIGS. 4A and 4B, the horizontal axis 80, 82 shows the time in milliseconds after the onset of the stimulus. In FIG. 4A, the vertical axis 84 shows the amplitude, in millivolts, of the response. In FIG. 4B, the vertical axis 86 shows the rate of change in the amplitude as a function of time.

The smallest response 88 was evoked with the initial stimulus intensity established in step 48 of the preferred method of FIG. 3. The remaining responses 90, 92, and 94 were evoked by stimuli with progressively higher intensities resulting from increases to the stimulus intensity in step 62 of the preferred method of FIG. 3. As can be seen from FIG. 4B, the peaks of the first derivatives of the responses 98, 100, 102 and 104 increase in parallel with the peaks of the responses 88, 90, 92, and 94.

The largest response 94 satisfied the branch condition in step 60 of the preferred method of FIG. 3. The peak of the first derivative of this response 104 was 0.502, while the peak of the first derivative of the response 102 evoked at the previous stimulus intensity was 0.457. The ratio (previous response over current response) between these two peaks was 0.91, which was larger than the preferred cutoff for the median motor nerve of 0.90, as described above. Thus, according to step 74 of the preferred method, the stimulus intensity that evoked response 94 or 96 represented a near maximal stimulus intensity that was suitable for measuring nerve responses of the median motor nerve for diagnostic purposes.

While the present invention has been described in terms of certain exemplary preferred embodiments, it will be readily understood and appreciated by one of ordinary skill in the art that it is not so limited, and that many additions, deletions, and modifications to the preferred embodiments may be made within the scope of the invention as hereinafter claimed. Accordingly, the scope of the invention is limited only by the scope of the appended claims.

Gozani, Shai N., Neimark, Matthew A., Turner, Christopher T.

Patent Priority Assignee Title
10029107, Jan 26 2017 Cardiac Pacemakers, Inc Leadless device with overmolded components
10039461, Nov 27 2012 Cadwell Laboratories, Inc. Neuromonitoring systems and methods
10046167, Feb 09 2015 Cardiac Pacemakers, Inc Implantable medical device with radiopaque ID tag
10050700, Mar 18 2015 Cardiac Pacemakers, Inc.; Cardiac Pacemakers, Inc Communications in a medical device system with temporal optimization
10052116, Oct 15 2004 SPINAL ELEMENTS, INC Devices and methods for treating tissue
10065041, Oct 08 2015 Cardiac Pacemakers, Inc Devices and methods for adjusting pacing rates in an implantable medical device
10092760, Sep 11 2015 Cardiac Pacemakers, Inc Arrhythmia detection and confirmation
10098585, Mar 15 2013 CADWELL LABORATORIES, INC Neuromonitoring systems and methods
10112040, Nov 15 2011 NEUROMETRIX, INC Transcutaneous electrical nerve stimulation using novel unbalanced biphasic waveform and novel electrode arrangement
10130810, Mar 29 2013 NeuroMetrix, Inc. Transcutaneous electrical nerve stimulator with user gesture detector and electrode-skin contact detector, with transient motion detector for increasing the accuracy of the same
10137305, Aug 28 2015 Cardiac Pacemakers, Inc Systems and methods for behaviorally responsive signal detection and therapy delivery
10154795, Aug 19 2005 Neuronetrix Solutions, LLC Controller for neuromuscular testing
10159835, Mar 29 2013 NeuroMetrix, Inc. Detecting cutaneous electrode peeling using electrode-skin impedance
10159842, Aug 28 2015 Cardiac Pacemakers, Inc System and method for detecting tamponade
10183170, Dec 17 2015 Cardiac Pacemakers, Inc. Conducted communication in a medical device system
10213610, Mar 18 2015 Cardiac Pacemakers, Inc Communications in a medical device system with link quality assessment
10220213, Feb 06 2015 Cardiac Pacemakers, Inc. Systems and methods for safe delivery of electrical stimulation therapy
10226631, Aug 28 2015 Cardiac Pacemakers, Inc Systems and methods for infarct detection
10238882, Feb 06 2015 Cardiac Pacemakers Systems and methods for treating cardiac arrhythmias
10251633, Jun 26 2002 NuVasive, Inc. Surgical access system and related methods
10279179, Apr 15 2013 NEUROMETRIX, INC Transcutaneous electrical nerve stimulator with automatic detection of user sleep-wake state
10293152, Jul 02 2008 Sage Products, LLC Devices, systems, and methods for automated optimization of energy delivery
10293159, Nov 15 2011 NeuroMetrix, Inc. Measuring the “on-skin” time of a transcutaneous electrical nerve stimulator (TENS) device in order to minimize skin irritation due to excessive uninterrupted wearing of the same
10299756, Sep 27 2005 NuVasive, Inc. System and methods for nerve monitoring
10321833, Oct 05 2016 Innovative Surgical Solutions.; Innovative Surgical Solutions, LLC Neural locating method
10327750, Apr 16 2009 NuVasive, Inc. Method and apparatus for performing spine surgery
10328272, May 10 2016 Cardiac Pacemakers, Inc Retrievability for implantable medical devices
10335595, Nov 15 2011 NEUROMETRIX, INC Dynamic control of transcutaneous electrical nerve stimulation therapy using continuous sleep detection
10350423, Feb 04 2016 Cardiac Pacemakers, Inc Delivery system with force sensor for leadless cardiac device
10357159, Aug 20 2015 Cardiac Pacemakers, Inc Systems and methods for communication between medical devices
10357233, Sep 25 2003 NuVasive, Inc. Surgical access system and related methods
10357238, Jan 16 2003 NuVasive, Inc. Surgical access system and related methods
10362957, Feb 02 2005 NuVasive, Inc. System and methods for performing neurophysiologic assessments during spine surgery
10363428, May 18 2005 Cardiac Pacemakers, Inc. Modular antitachyarrhythmia therapy system
10376208, Sep 20 2013 Innovative Surgical Solutions, LLC Nerve mapping system
10376209, Sep 20 2013 Innovative Surgical Solutions, LLC Neural locating method
10384063, Apr 15 2014 NEUROMETRIX, INC Apparatus and method for automated compensation of transcutaneous electrical nerve stimulation for temporal fluctuations such as circadian rhythms
10391319, Aug 19 2016 Cardiac Pacemakers, Inc Trans septal implantable medical device
10413733, Oct 27 2016 Cardiac Pacemakers, Inc. Implantable medical device with gyroscope
10420480, Sep 16 2014 NuVasive, Inc Systems and methods for performing neurophysiologic monitoring
10426627, Apr 16 2009 NuVasive, Inc. Methods and apparatus for performing spine surgery
10426962, Jul 07 2016 Cardiac Pacemakers, Inc. Leadless pacemaker using pressure measurements for pacing capture verification
10433793, Mar 27 2015 CADWELL LABORATORIES, INC Methods and systems for simultaneous review of brain activity and physical manifestations of users
10434314, Oct 27 2016 Cardiac Pacemakers, Inc. Use of a separate device in managing the pace pulse energy of a cardiac pacemaker
10434317, Oct 31 2016 Cardiac Pacemakers, Inc. Systems and methods for activity level pacing
10441183, Sep 22 2005 NuVasive, Inc. Multi-channel stimulation threshold detection algorithm for use with neurophysiology monitoring systems
10449002, Sep 20 2013 Innovative Surgical Solutions, LLC Method of mapping a nerve
10463305, Oct 27 2016 Cardiac Pacemakers, Inc. Multi-device cardiac resynchronization therapy with timing enhancements
10470707, Oct 30 2001 NuVasive, Inc. System and methods for performing percutaneous pedicle integrity assessments
10471276, Oct 07 2015 The Regents of the University of California Apparatus and method for photonic physiological and neurological stimulation
10478096, Aug 13 2013 Innovative Surgical Solutions. Neural event detection
10478097, Aug 13 2013 Innovative Surgical Solutions Neural event detection
10478622, Nov 11 2009 Sage Products, LLC Synergistic muscle activation device
10507120, Sep 25 2001 NuVasive, Inc. Systems and methods for performing surgical procedures and assessments
10512784, Jun 27 2016 Cardiac Pacemakers, Inc. Cardiac therapy system using subcutaneously sensed P-waves for resynchronization pacing management
10561330, Oct 27 2016 Cardiac Pacemakers, Inc. Implantable medical device having a sense channel with performance adjustment
10583301, Nov 08 2016 Cardiac Pacemakers, Inc. Implantable medical device for atrial deployment
10583303, Jan 19 2016 Devices and methods for wirelessly recharging a rechargeable battery of an implantable medical device
10589101, Aug 28 2015 Cardiac Pacemakers, Inc. System and method for detecting tamponade
10617874, Oct 31 2016 Cardiac Pacemakers, Inc. Systems and methods for activity level pacing
10631782, Apr 30 2010 J3G Spine, LLC Devices and methods for nerve mapping
10632313, Nov 09 2016 Cardiac Pacemakers, Inc. Systems, devices, and methods for setting cardiac pacing pulse parameters for a cardiac pacing device
10639486, Nov 21 2016 Cardiac Pacemakers, Inc. Implantable medical device with recharge coil
10653308, Oct 17 2003 NuVasive, Inc. Surgical access system and related methods
10668294, May 10 2016 Cardiac Pacemakers, Inc Leadless cardiac pacemaker configured for over the wire delivery
10688304, Jul 20 2016 Cardiac Pacemakers, Inc Method and system for utilizing an atrial contraction timing fiducial in a leadless cardiac pacemaker system
10695044, Oct 08 2002 NuVasive, Inc. Surgical access system and related methods
10695108, May 08 2003 NuVasive, Inc. Neurophysiological apparatus and procedures
10709892, Aug 27 2015 Cardiac Pacemakers, Inc. Temporal configuration of a motion sensor in an implantable medical device
10716509, Jul 11 2001 NuVasive, Inc. System and methods for determining nerve proximity, direction and pathology during surgery
10722720, Jan 10 2014 Cardiac Pacemakers, Inc. Methods and systems for improved communication between medical devices
10737102, Jan 26 2017 Cardiac Pacemakers, Inc Leadless implantable device with detachable fixation
10758724, Oct 27 2016 Cardiac Pacemakers, Inc. Implantable medical device delivery system with integrated sensor
10758737, Sep 21 2016 Cardiac Pacemakers, Inc. Using sensor data from an intracardially implanted medical device to influence operation of an extracardially implantable cardioverter
10765871, Oct 27 2016 Cardiac Pacemakers, Inc. Implantable medical device with pressure sensor
10780269, Nov 15 2011 NeuroMetrix, Inc. Apparatus and method for relieving pain using transcutaneous electrical nerve stimulation
10780278, Aug 24 2016 Cardiac Pacemakers, Inc. Integrated multi-device cardiac resynchronization therapy using P-wave to pace timing
10821288, Apr 03 2017 Cardiac Pacemakers, Inc. Cardiac pacemaker with pacing pulse energy adjustment based on sensed heart rate
10835753, Jan 26 2017 Cardiac Pacemakers, Inc. Intra-body device communication with redundant message transmission
10864365, Nov 15 2011 NeuroMetrix, Inc. Transcutaneous electrical nerve stimulation using novel unbalanced biphasic waveform and novel electrode arrangement
10869616, Jun 01 2018 DEPUY SYNTHES PRODUCTS, INC Neural event detection
10870002, Oct 12 2018 DEPUY SYNTHES PRODUCTS, INC Neuromuscular sensing device with multi-sensor array
10870008, Aug 24 2016 Cardiac Pacemakers, Inc. Cardiac resynchronization using fusion promotion for timing management
10874861, Jan 04 2018 Cardiac Pacemakers, Inc. Dual chamber pacing without beat-to-beat communication
10881863, Nov 21 2016 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker with multimode communication
10881869, Nov 21 2016 Cardiac Pacemakers, Inc. Wireless re-charge of an implantable medical device
10894163, Nov 21 2016 Cardiac Pacemakers, Inc. LCP based predictive timing for cardiac resynchronization
10905872, Apr 03 2017 Cardiac Pacemakers, Inc. Implantable medical device with a movable electrode biased toward an extended position
10905886, Dec 28 2015 Cardiac Pacemakers, Inc Implantable medical device for deployment across the atrioventricular septum
10905889, Sep 21 2016 Cardiac Pacemakers, Inc. Leadless stimulation device with a housing that houses internal components of the leadless stimulation device and functions as the battery case and a terminal of an internal battery
10912943, Aug 06 2014 Cardiac Pacemakers, Inc. Communications between a plurality of medical devices using time delays between communication pulses between symbols
10918875, Aug 18 2017 Cardiac Pacemakers, Inc. Implantable medical device with a flux concentrator and a receiving coil disposed about the flux concentrator
10933245, Dec 17 2015 Cardiac Pacemakers, Inc. Conducted communication in a medical device system
10940311, Mar 29 2013 NEUROMETRIX, INC Apparatus and method for button-free control of a wearable transcutaneous electrical nerve stimulator using interactive gestures and other means
10945621, Nov 27 2012 Cadwell Laboratories, Inc. Neuromonitoring systems and methods
10946202, Mar 18 2015 Cardiac Pacemakers, Inc. Communications in a medical device system with link quality assessment
10959860, Dec 26 2008 Pantheon Spinal, LLC Method of retroperitoneal lateral insertion of spinal implants
10980524, Jun 26 2002 NuVasive, Inc. Surgical access system and related methods
10987510, Jul 02 2008 Sage Products, LLC Systems and methods for automated muscle stimulation
10993650, Jan 15 2003 NuVasive, Inc. System for determining nerve direction to a surgical instrument
10994145, Sep 21 2016 Cardiac Pacemakers, Inc. Implantable cardiac monitor
11020595, Feb 06 2015 Cardiac Pacemakers, Inc. Systems and methods for treating cardiac arrhythmias
11020600, Feb 09 2015 Cardiac Pacemakers, Inc. Implantable medical device with radiopaque ID tag
11026627, Mar 15 2013 Cadwell Laboratories, Inc. Surgical instruments for determining a location of a nerve during a procedure
11033218, Feb 02 2005 NuVasive, Inc. System and methods for performing neurophysiologic assessments during spine surgery
11051736, Dec 08 2008 Medtronic Xomed, Inc. Method and system for monitoring a nerve
11052258, Dec 01 2017 Cardiac Pacemakers, Inc Methods and systems for detecting atrial contraction timing fiducials within a search window from a ventricularly implanted leadless cardiac pacemaker
11058877, May 30 2017 NEUROMETRIX, INC Apparatus and method for the automated control of transcutaneous electrical nerve stimulation based on current and forecasted weather conditions
11058880, Mar 23 2018 Medtronic, Inc VFA cardiac therapy for tachycardia
11064934, Sep 25 2003 NuVasive, Inc. Surgical access system and related methods
11065459, Aug 18 2017 Cardiac Pacemakers, Inc. Implantable medical device with pressure sensor
11071870, Dec 01 2017 Cardiac Pacemakers, Inc Methods and systems for detecting atrial contraction timing fiducials and determining a cardiac interval from a ventricularly implanted leadless cardiac pacemaker
11083898, May 18 2005 Cardiac Pacemakers, Inc. Modular antitachyarrhythmia therapy system
11116988, Mar 31 2016 Cardiac Pacemakers, Inc Implantable medical device with rechargeable battery
11128076, Jan 21 2019 CADWELL LABORATORIES, INC Connector receptacle
11147979, Nov 21 2016 Cardiac Pacemakers, Inc. Implantable medical device with a magnetically permeable housing and an inductive coil disposed about the housing
11177610, Jan 23 2017 Cadwell Laboratories, ino. Neuromonitoring connection system
11185684, Sep 18 2018 Minimally invasive two-dimensional grid electrode
11185703, Nov 07 2017 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker for bundle of his pacing
11191443, Mar 29 2013 NeuroMetrix, Inc. Detecting cutaneous electrode peeling using electrode-skin impedance
11207527, Jul 06 2016 Cardiac Pacemakers, Inc. Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system
11207532, Jan 04 2017 Cardiac Pacemakers, Inc. Dynamic sensing updates using postural input in a multiple device cardiac rhythm management system
11213676, Apr 01 2019 Medtronic, Inc Delivery systems for VfA cardiac therapy
11219440, Jan 16 2003 NuVasive, Inc. Surgical access system and related methods
11224751, Feb 06 2015 Cardiac Pacemakers, Inc. Systems and methods for safe delivery of electrical stimulation therapy
11235142, Dec 23 2016 NEUROMETRIX, INC “Smart” electrode assembly for transcutaneous electrical nerve stimulation (TENS)
11235159, Mar 23 2018 Medtronic, Inc VFA cardiac resynchronization therapy
11235161, Sep 26 2018 Medtronic, Inc Capture in ventricle-from-atrium cardiac therapy
11235163, Sep 20 2017 Cardiac Pacemakers, Inc. Implantable medical device with multiple modes of operation
11246713, Apr 16 2009 NuVasive, Inc. Methods and apparatus for performing spine surgery
11247040, Nov 15 2011 NeuroMetrix, Inc. Dynamic control of transcutaneous electrical nerve stimulation therapy using continuous sleep detection
11247052, Apr 15 2013 NeuroMetrix, Inc. Transcutaneous electrical nerve stimulator with automatic detection of user sleep-wake state
11253182, May 04 2018 CADWELL LABORATORIES, INC Apparatus and method for polyphasic multi-output constant-current and constant-voltage neurophysiological stimulation
11259737, Nov 06 2012 NuVasive, Inc Systems and methods for performing neurophysiologic monitoring during spine surgery
11259744, Nov 15 2011 NeuroMetrix, Inc. Transcutaneous electrical nerve stimulator with automatic detection of leg orientation and leg motion for enhanced sleep analysis, including enhanced transcutaneous electrical nerve stimulation (TENS) using the same
11260216, Dec 01 2017 Cardiac Pacemakers, Inc Methods and systems for detecting atrial contraction timing fiducials during ventricular filling from a ventricularly implanted leadless cardiac pacemaker
11285326, Mar 04 2015 Cardiac Pacemakers, Inc. Systems and methods for treating cardiac arrhythmias
11305125, Oct 27 2016 Cardiac Pacemakers, Inc. Implantable medical device with gyroscope
11305127, Aug 26 2019 Medtronic, Inc VfA delivery and implant region detection
11311222, Oct 05 2016 Innovative Surgical Solutions Neural locating system
11317841, Nov 14 2018 Method and system for electrode verification
11382647, Oct 15 2004 Spinal Elements, Inc. Devices and methods for treating tissue
11399777, Sep 27 2019 DEPUY SYNTHES PRODUCTS, INC Intraoperative neural monitoring system and method
11400296, Mar 23 2018 MEDTRONIC, INC Q; Medtronic, Inc AV synchronous VfA cardiac therapy
11439831, Oct 26 2006 Boston Scientific Neuromodulation Corporation Automatic adjustment to maintain evoked potential feature
11443649, Jun 29 2018 CADWELL LABORATORIES, INC Neurophysiological monitoring training simulator
11457857, Sep 22 2005 NuVasive, Inc. Multi-channel stimulation threshold detection algorithm for use with neurophysiology monitoring systems
11464982, Aug 24 2016 Cardiac Pacemakers, Inc. Integrated multi-device cardiac resynchronization therapy using p-wave to pace timing
11471086, Sep 16 2014 NuVasive, Inc. Systems and methods for performing neurophysiologic monitoring
11471087, Nov 09 2018 CADWELL LABORATORIES, INC Integrity verification system for testing high channel count neuromonitoring recording equipment
11476927, Mar 18 2015 Cardiac Pacemakers, Inc. Communications in a medical device system with temporal optimization
11497543, Apr 28 2017 Stryker Corporation Control console and accessories for RF nerve ablation and methods of operating the same
11497921, Jun 27 2016 Cardiac Pacemakers, Inc. Cardiac therapy system using subcutaneously sensed p-waves for resynchronization pacing management
11511106, Nov 15 2011 NeuroMetrix, Inc. Transcutaneous electrical nerve stimulation using novel unbalanced biphasic waveform and novel electrode arrangement
11517239, Apr 05 2018 CADWELL LABORATORIES, INC Systems and methods for processing and displaying electromyographic signals
11517245, Oct 30 2018 CADWELL LABORATORIES, INC Method and system for data synchronization
11529107, Nov 27 2018 CADWELL LABORATORIES, INC Methods for automatic generation of EEG montages
11529523, Jan 04 2018 Cardiac Pacemakers, Inc. Handheld bridge device for providing a communication bridge between an implanted medical device and a smartphone
11540804, Sep 27 2005 NuVasive, Inc. System and methods for nerve monitoring
11590353, Jan 26 2017 Cardiac Pacemakers, Inc. Intra-body device communication with redundant message transmission
11596337, Apr 24 2018 CADWELL LABORATORIES, INC Methods and systems for operating an intraoperative neurophysiological monitoring system in conjunction with electrocautery procedures
11612344, Nov 02 2018 BIOCIRCUIT TECHNOLOGIES, INC Electrode-based systems and devices for interfacing with biological tissue and related methods
11617562, Sep 27 2005 NuVasive, Inc. System and methods for nerve monitoring
11647999, Apr 16 2009 NuVasive, Inc. Method and apparatus for performing spine surgery
11653894, Sep 27 2005 NuVasive, Inc. System and methods for nerve monitoring
11679265, Feb 14 2019 Medtronic, Inc. Lead-in-lead systems and methods for cardiac therapy
11684310, Apr 30 2010 J3G Spine, LLC Devices and methods for nerve mapping
11697025, Mar 29 2019 Medtronic, Inc Cardiac conduction system capture
11712188, May 07 2019 Medtronic, Inc. Posterior left bundle branch engagement
11712218, Sep 27 2005 NuVasive, Inc. System and methods for nerve monitoring
11717682, Nov 15 2011 NEUROMETRIX, INC Apparatus and method for relieving pain using transcutaneous electrical nerve stimulation
11723644, Oct 08 2004 NuVasive, Inc. Surgical access system and related methods
11730959, Mar 29 2013 NeuroMetrix, Inc. Apparatus and method for button-free control of a wearable transcutaneous electrical nerve stimulator using interactive gestures and other means
11752335, Feb 07 2018 Mary Kay Inc. Method for determining facial muscle responses
11777243, Jan 21 2019 Cadwell Laboratories, Inc. Connector receptacle with improved mating retention and release
11793447, Feb 02 2005 NuVasive, Inc. System and methods for performing neurophysiologic assessments during spine surgery
11793504, Aug 19 2011 NuVasive, Inc. Surgical retractor system and methods of use
11813463, Dec 01 2017 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker with reversionary behavior
11813464, Jul 31 2020 Medtronic, Inc. Cardiac conduction system evaluation
11813466, Jan 27 2020 Medtronic, Inc Atrioventricular nodal stimulation
11819699, Mar 23 2018 Medtronic, Inc. VfA cardiac resynchronization therapy
11839763, Nov 11 2009 Sage Products, LLC Synergistic muscle activation device
11877860, Nov 06 2012 NuVasive, Inc Systems and methods for performing neurophysiologic monitoring during spine surgery
11883661, Dec 07 2018 NEUROMETRIX, INC Intelligent determination of therapeutic stimulation intensity for transcutaneous electrical nerve stimulation
11896378, Nov 09 2018 CADWELL LABORATORIES, INC Integrity verification system for testing high channel count neuromonitoring recording equipment
11911168, Apr 03 2020 Medtronic, Inc. Cardiac conduction system therapy benefit determination
6466817, Nov 24 1999 NuVasive, Inc Nerve proximity and status detection system and method
6500128, Jun 08 2000 NuVasive, Inc Nerve movement and status detection system and method
7020521, Nov 08 2002 Pacesetter, Inc Methods and apparatus for detecting and/or monitoring heart failure
7079883, Dec 23 1998 NuVaslve, Inc. Nerve surveillance cannulae systems
7177677, Nov 24 1999 NuVasive, Inc. Nerve proximity and status detection system and method
7207949, May 25 2005 NuVasive, Inc Surgical access system and related methods
7470236, Nov 24 1999 NuVasive, Inc Electromyography system
7522953, Sep 25 2001 NuVasive, Inc System and methods for performing surgical procedures and assessments
7582058, Jun 26 2002 NuVasive, Inc Surgical access system and related methods
7643884, Jan 31 2005 Warsaw Orthopedic, Inc Electrically insulated surgical needle assembly
7657308, Aug 05 2003 NuVasive, Inc System and methods for performing dynamic pedicle integrity assessments
7664544, Oct 30 2002 NuVasive, Inc System and methods for performing percutaneous pedicle integrity assessments
7691057, Jan 16 2003 NuVasive, Inc Surgical access system and related methods
7693562, Dec 23 1998 NuVasive, Inc. Nerve surveillance cannulae systems
7785253, Jan 31 2005 NuVasive, Inc.; NuVasive, Inc Surgical access system and related methods
7799021, Aug 04 2004 CITIBANK, N A Electrosurgical treatment in conjunction with monitoring
7819801, Feb 27 2003 NuVasive, Inc Surgical access system and related methods
7857813, Aug 29 2006 SPINAL ELEMENTS, INC Tissue access guidewire system and method
7887538, Oct 15 2005 SPINAL ELEMENTS, INC Methods and apparatus for tissue modification
7892173, Feb 27 2003 NuVasive, Inc. Surgical access system and related methods
7905840, Oct 17 2003 NuVasive, Inc Surgical access system and related methods
7918849, Oct 15 2004 SPINAL ELEMENTS, INC Devices and methods for tissue access
7920922, Jul 11 2001 NuVasive, Inc. System and methods for determining nerve proximity, direction, and pathology during surgery
7935051, Jun 26 2002 NuVasive, Inc. Surgical access system and related methods
7938830, Oct 15 2004 SPINAL ELEMENTS, INC Powered tissue modification devices and methods
7959577, Sep 06 2007 SPINAL ELEMENTS, INC Method, system, and apparatus for neural localization
7962191, Dec 23 1998 NuVasive, Inc. Nerve surveillance cannulae systems
7963915, Oct 15 2004 SPINAL ELEMENTS, INC Devices and methods for tissue access
7963927, Nov 24 1999 NuVasive, Inc. Electromyography system
7987001, Jan 25 2007 Warsaw Orthopedic, Inc. Surgical navigational and neuromonitoring instrument
7991463, Oct 31 2007 NuVasive, Inc. Electromyography system
8000782, Sep 25 2002 NuVasive, Inc. System and methods for performing surgical procedures and assessments
8005535, Sep 25 2001 NuVasive, Inc. System and methods for performing surgical procedures and assessments
8016767, Sep 25 2003 NuVasive, Inc. Surgical access system and related methods
8027716, Sep 25 2001 NuVasive, Inc. System and methods for performing surgical procedures and assessments
8048080, Oct 15 2004 SPINAL ELEMENTS, INC Flexible tissue rasp
8050769, Jul 11 2002 NuVasive, Inc. System and methods for determining nerve proximity, direction, and pathology during surgery
8062298, May 04 2006 SPINAL ELEMENTS, INC Flexible tissue removal devices and methods
8062300, May 04 2006 SPINAL ELEMENTS, INC Tissue removal with at least partially flexible devices
8068912, Jul 11 2001 NuVasive, Inc System and methods for determining nerve proximity, direction, and pathology during surgery
8090436, May 18 2000 NuVasive, Inc. Tissue discrimination and applications in medical procedures
8092455, Feb 07 2005 Warsaw Orthopedic, Inc Device and method for operating a tool relative to bone tissue and detecting neural elements
8092456, Oct 15 2005 SPINAL ELEMENTS, INC Multiple pathways for spinal nerve root decompression from a single access point
8114019, Jan 16 2003 NuVasive, Inc. Surgical access system and related methods
8133173, Jan 16 2003 NuVasive, Inc. Surgical access system and related methods
8137284, Oct 08 2002 NuVasive, Inc Surgical access system and related methods
8147421, Jan 15 2003 NuVasive, Inc System and methods for determining nerve direction to a surgical instrument
8165653, Dec 23 1998 NuVasive, Inc. Surgical access and nerve surveillance
8172750, Jan 16 2003 NuVasive, Inc. Surgical access system and related methods
8182423, Jun 26 2002 NuVasive, Inc. Surgical access system and related methods
8187179, Jun 26 2002 NuVasive, Inc. Surgical access system and related methods
8192356, Jun 26 2002 NuVasive, Inc. Surgical access system and related methods
8192357, Oct 08 2002 NuVasive, Inc Surgical access system and related methods
8192435, Oct 15 2004 SPINAL ELEMENTS, INC Devices and methods for tissue modification
8192436, Dec 07 2007 SPINAL ELEMENTS, INC Tissue modification devices
8206312, Sep 22 2005 NuVasive, Inc Multi-channel stimulation threshold detection algorithm for use in neurophysiology monitoring
8221397, Oct 15 2004 SPINAL ELEMENTS, INC Devices and methods for tissue modification
8244343, Sep 25 2001 NuVasive, Inc. System and methods for performing surgical procedures and assessments
8255044, Aug 05 2003 NuVasive, Inc. System and methods for performing dynamic pedicle integrity assessments
8255045, Apr 04 2007 NuVasive, Inc Neurophysiologic monitoring system
8257356, Oct 15 2004 SPINAL ELEMENTS, INC Guidewire exchange systems to treat spinal stenosis
8265744, Sep 25 2002 NuVasive, Inc. Systems and methods for performing surgical procedures and assessments
8265763, Aug 26 2008 Sage Products, LLC Device, system, and method to improve powered muscle stimulation performance in the presence of tissue edema
8285381, Jul 02 2008 Sage Products, LLC Systems and methods for automated muscle stimulation
8287597, Apr 16 2009 SOLTA MEDICAL, INC Method and apparatus for performing spine surgery
8303498, Feb 27 2003 NuVasive, Inc. Surgical access system and related methods
8303515, Sep 25 2003 NuVasive, Inc. Surgical access system and related methods
8303516, Sep 06 2007 SPINAL ELEMENTS, INC Method, system and apparatus for neural localization
8313430, Jan 11 2006 NuVasive, Inc. Surgical access system and related methods
8326410, Feb 17 2004 NEUROMETRIX, INC Method for automated analysis of submaximal F-waves
8328851, Jul 28 2005 NuVasive, Inc Total disc replacement system and related methods
8337410, Nov 24 1999 Nu Vasive, Inc. Electromyography system
8343046, Jan 16 2003 NuVasive, Inc. Surgical access system and related methods
8355780, Sep 25 2003 NuVasive, Inc. Surgical access system and related methods
8366712, Oct 15 2005 SPINAL ELEMENTS, INC Multiple pathways for spinal nerve root decompression from a single access point
8374673, Jan 25 2007 Warsaw Orthopedic, Inc. Integrated surgical navigational and neuromonitoring system having automated surgical assistance and control
8388527, Sep 25 2003 NuVasive, Inc. Surgical access system and related method
8394102, Jun 25 2009 SPINAL ELEMENTS, INC Surgical tools for treatment of spinal stenosis
8398641, Jul 01 2008 SPINAL ELEMENTS, INC Tissue modification devices and methods
8403841, Jan 16 2003 NuVasive, Inc. Surgical access system and related methods
8409206, Jul 01 2008 SPINAL ELEMENTS, INC Tissue modification devices and methods
8419653, May 16 2005 SPINAL ELEMENTS, INC Spinal access and neural localization
8425430, Jan 31 2005 Warsaw Orthopedic, Inc. Electrically insulated surgical needle assembly
8430881, Oct 15 2004 SPINAL ELEMENTS, INC Mechanical tissue modification devices and methods
8433403, Feb 20 2009 Sage Products, LLC Systems and methods of powered muscle stimulation using an energy guidance field
8439832, Jan 16 2003 NuVasive, Inc. Surgical access system and related methods
8500634, Sep 25 2003 NuVasive, Inc. Surgical access system and related methods
8500653, Sep 22 2005 NuVasive, Inc. Neurophysiology monitoring system configured for rapid stimulation threshold acquisition
8512235, Oct 08 2002 NuVasive, Inc. Surgical access system and related methods
8515520, Dec 08 2008 Medtronic Xomed, Inc Nerve electrode
8523768, Jan 16 2003 NuVasive, Inc. Surgical access system and related methods
8538539, Oct 07 2004 NuVasive, Inc System and methods for assessing the neuromuscular pathway prior to nerve testing
8548579, Sep 25 2001 NuVasive, Inc. System and methods for performing surgical procedures and assessments
8550994, Feb 27 2003 NuVasive, Inc. Surgical access system and related methods
8551097, Aug 29 2006 SPINAL ELEMENTS, INC Tissue access guidewire system and method
8556808, Sep 25 2003 NuVasive, Inc. Surgical access system and related methods
8562521, Jan 16 2003 NuVasive, Inc. Surgical access system and related methods
8562539, Nov 24 1999 NuVasive, Inc. Electromyography system
8568317, Sep 27 2005 NuVasive, Inc System and methods for nerve monitoring
8568331, Feb 02 2005 NuVasive, Inc System and methods for monitoring during anterior surgery
8568416, Oct 15 2004 SPINAL ELEMENTS, INC Access and tissue modification systems and methods
8579902, Oct 15 2004 SPINAL ELEMENTS, INC Devices and methods for tissue modification
8585704, May 04 2006 SPINAL ELEMENTS, INC Flexible tissue removal devices and methods
8588901, Nov 11 2009 Sage Products, LLC Synergistic muscle activation device
8591431, Sep 22 2005 NuVasive, Inc System and methods for performing pedicle integrity assessments of the thoracic spine
8591432, Sep 25 2003 NuVasive, Inc. Surgical access system and related methods
8602982, Jan 16 2003 NuVasive, Inc. Surgical access system and related methods
8613745, Oct 15 2004 SPINAL ELEMENTS, INC Methods, systems and devices for carpal tunnel release
8617163, Oct 15 2004 SPINAL ELEMENTS, INC Methods, systems and devices for carpal tunnel release
8628469, Sep 25 2003 NuVasive, Inc. Surgical access system and related methods
8634904, Jul 11 2001 NuVasive, Inc. System and methods for determining nerve proximity, direction, and pathology during surgery
8641638, Nov 24 1999 NuVasive, Inc. Electromyography system
8647346, Oct 15 2004 SPINAL ELEMENTS, INC Devices and methods for tissue modification
8652138, Oct 15 2004 SPINAL ELEMENTS, INC Flexible tissue rasp
8652140, Feb 07 2005 Warsaw Orthopedic, Inc. Device and method for operating a tool relative to bone tissue and detecting neural elements
8663100, Oct 08 2002 NuVasive, Inc. Surgical access system and related methods
8663228, Dec 07 2007 SPINAL ELEMENTS, INC Tissue modification devices
8672840, Jun 26 2002 NuVasive, Inc. Surgical access system and related methods
8676332, Feb 20 2009 Sage Products, LLC Systems and methods of powered muscle stimulation using an energy guidance field
8679006, Oct 08 2002 NuVasive, Inc. Surgical access system and related methods
8696559, Feb 27 2003 NuVasive, Inc. Surgical access system and related methods
8708899, Jun 26 2002 NuVasive, Inc. Surgical access system and related methods
8738123, Sep 25 2001 NuVasive, Inc. System and methods for performing surgical procedures and assessments
8740783, Jul 20 2005 NuVasive, Inc System and methods for performing neurophysiologic assessments with pressure monitoring
8747307, Jan 16 2003 NuVasive, Inc. Surgical access system and related methods
8753270, Jan 16 2004 NuVasive, Inc. Surgical access system and related methods
8753271, Sep 25 2003 NuVasive, Inc. Surgical access system and related methods
8764649, Sep 25 2003 NuVasive, Inc. Surgical access system and related methods
8768450, Sep 25 2001 NuVasive, Inc. System and methods for performing surgical procedures and assessments
8790406, Apr 01 2011 Systems and methods for performing spine surgery
8801626, Oct 15 2005 SPINAL ELEMENTS, INC Flexible neural localization devices and methods
8812116, Jul 11 2001 NuVasive, Inc. System and methods for determining nerve proximity, direction, and pathology during surgery
8821396, Sep 25 2003 NuVasive, Inc. Surgical access system and related methods
8827900, Jan 11 2006 NuVasive, Inc. Surgical access system and related methods
8845637, Aug 29 2006 SPINAL ELEMENTS, INC Tissue access guidewire system and method
8845639, Jul 14 2008 SPINAL ELEMENTS, INC Tissue modification devices
8870960, Jul 28 2005 NuVasive, Inc. Total disc replacement system and related methods
8892210, Jul 02 2008 Sage Products, LLC Devices, systems, and methods for automated optimization of energy delivery
8915846, Jun 26 2002 NuVasive, Inc. Surgical access system and related methods
8920500, Apr 16 2009 NuVasive, Inc. Methods and apparatus for performing spine surgery
8942801, Sep 27 2004 NuVasive, Inc. Surgical access system and related methods
8945004, Sep 25 2003 NuVasive, Inc. Surgical access system and related methods
8948876, Nov 15 2011 NEUROMETRIX, INC Apparatus and method for relieving pain using transcutaneous electrical nerve stimulation
8956283, Oct 08 2002 NuVasive, Inc. Surgical access system and related methods
8958869, Nov 24 1999 NuVasive, Inc. Electromyography system
8977352, Sep 25 2001 NuVasive, Inc. Systems and methods for performing surgical procedures and assessments
8989866, Oct 07 2004 NuVasive, Inc. System and methods for assessing the neuromuscular pathway prior to nerve testing
9002467, May 18 2005 Cardiac Pacemakers, Inc. Modular antitachyarrhythmia therapy system
9014776, Dec 23 1998 NuVasive, Inc. Surgical access and nerve surveillance
9037250, Jul 11 2001 NuVasive, Inc. System and methods for determining nerve proximity, direction and pathology during surgery
9042978, May 11 2007 NEUROMETRIX, INC Method and apparatus for quantitative nerve localization
9066701, Feb 06 2012 NuVasive, Inc Systems and methods for performing neurophysiologic monitoring during spine surgery
9084551, Dec 08 2008 Medtronic Xomed, Inc Method and system for monitoring a nerve
9101386, Oct 15 2004 SPINAL ELEMENTS, INC Devices and methods for treating tissue
9125682, Oct 15 2005 SPINAL ELEMENTS, INC Multiple pathways for spinal nerve root decompression from a single access point
9126039, Nov 11 2009 Sage Products, LLC Synergistic muscle activation device
9131947, Jan 23 2009 NuVasive, Inc. Neurophysiological apparatus and procedures
9149386, Feb 20 2009 Sage Products, LLC Devices and systems for stimulation of tissues
9155503, Oct 27 2010 Cadwell Labs Apparatus, system, and method for mapping the location of a nerve
9168149, Jul 28 2005 NaVasive, Inc. Total disc replacement system and related methods
9192482, Apr 16 2009 NuVasive, Inc. Methods and apparatus for performing spine surgery
9198765, Oct 31 2011 NuVasive, Inc Expandable spinal fusion implants and related methods
9204871, Oct 08 2002 NuVasive, Inc. Surgical access system and related methods
9242113, May 18 2005 Cardiac Pacemarkers, Inc. Modular antitachyarrhythmia therapy system
9247952, Oct 15 2004 SPINAL ELEMENTS, INC Devices and methods for tissue access
9265493, Sep 25 2003 NuVasive, Inc. Surgical access system and related methods
9295396, Apr 03 2007 NuVasive, Inc. Neurophysiologic monitoring system
9295401, Nov 27 2012 CADWELL LABORATORIES, INC Neuromonitoring systems and methods
9301743, Jan 16 2003 NuVasive, Inc. Surgical access system and related methods
9302104, Jul 02 2008 Sage Products, LLC Devices, systems, and methods for automated optimization of energy delivery
9314152, Oct 17 2003 NuVasive, Inc. Surgical access system and related methods
9314253, Jul 01 2008 SPINAL ELEMENTS, INC Tissue modification devices and methods
9320618, Oct 15 2004 SPINAL ELEMENTS, INC Access and tissue modification systems and methods
9345491, Oct 15 2004 SPINAL ELEMENTS, INC Flexible tissue rasp
9351741, May 04 2006 SPINAL ELEMENTS, INC Flexible tissue removal devices and methods
9351845, Apr 16 2009 NuVasive, Inc Method and apparatus for performing spine surgery
9352164, May 18 2005 Cardiac Pacemakers, Inc. Modular antitachyarrhythmia therapy system
9392953, Sep 17 2010 NuVasive, Inc Neurophysiologic monitoring
9456783, Jul 11 2001 NuVasive, Inc. System and methods for determining nerve proximity, direction and pathology during surgery
9456829, Oct 15 2004 SPINAL ELEMENTS, INC Powered tissue modification devices and methods
9463029, Dec 07 2007 SPINAL ELEMENTS, INC Tissue modification devices
9463041, Oct 15 2004 SPINAL ELEMENTS, INC Devices and methods for tissue access
9468405, Feb 27 2003 NuVasive, Inc. Surgical access system and related methods
9474898, Mar 29 2013 NEUROMETRIX, INC Detecting cutaneous electrode peeling using electrode-skin impedance
9492151, Oct 15 2005 SPINAL ELEMENTS, INC Multiple pathways for spinal nerve root decompression from a single access point
9526909, Aug 28 2014 Cardiac Pacemakers, Inc. Medical device with triggered blanking period
9532899, Feb 20 2009 Sage Products, LLC Devices and systems for stimulation of tissue
9572562, Oct 08 2002 NuVasive, Inc. Surgical access system and related methods
9579037, Dec 08 2008 Medtronic Xomed, Inc. Method and system for monitoring a nerve
9592391, Jan 10 2014 Cardiac Pacemakers, Inc. Systems and methods for detecting cardiac arrhythmias
9610071, Sep 25 2003 NuVasive, Inc. Surgical access system and related methods
9610171, Jul 28 2005 NuVasive, Inc. Total disc replacement system and related methods
9622732, Oct 08 2004 NuVasive, Inc Surgical access system and related methods
9655505, Feb 06 2012 NuVasive, Inc Systems and methods for performing neurophysiologic monitoring during spine surgery
9655744, Oct 31 2011 NuVasive, Inc. Expandable spinal fusion implants and related methods
9656070, Nov 15 2011 NeuroMetrix, Inc. Apparatus and method for relieving pain using transcutaneous electrical nerve stimulation
9669230, Feb 06 2015 Cardiac Pacemakers, Inc.; GM Global Technology Operations LLC Systems and methods for treating cardiac arrhythmias
9675801, Nov 15 2011 NEUROMETRIX, INC Measuring the “on-skin” time of a transcutaneous electrical nerve stimulator (TENS) device in order to minimize skin irritation due to excessive uninterrupted wearing of the same
9681880, Feb 07 2005 Warsaw Orthopedic, Inc. Device and method for operating a tool relative to bone tissue and detecting neural elements
9694189, Aug 06 2014 Cardiac Pacemakers, Inc. Method and apparatus for communicating between medical devices
9700228, Feb 02 2005 NuVasive, Inc. System and methods for performing neurophysiologic assessments during spine surgery
9730634, Oct 27 2010 Cadwell Labs Apparatus, system, and method for mapping the location of a nerve
9731126, Nov 15 2011 NEUROMETRIX, INC Transcutaneous electrical nerve stimulator with automatic detection of leg orientation and leg motion for enhanced sleep analysis, including enhanced transcutaneous electrical nerve stimulation (TENS) using the same
9743853, Nov 24 1999 NuVasive, Inc. Electromyography system
9743884, Apr 30 2010 J3G Spine, LLC Devices and methods for nerve mapping
9750490, Jun 26 2002 NuVasive, Inc. Surgical access system and related methods
9757067, Nov 09 2012 NuVasive, Inc Systems and methods for performing neurophysiologic monitoring during spine surgery
9757072, Feb 11 2013 NuVasive, Inc Waveform marker placement algorithm for use in neurophysiologic monitoring
9757246, Apr 16 2009 NuVasive, Inc. Methods and apparatus for performing spine surgery
9757570, Aug 06 2014 Cardiac Pacemakers, Inc. Communications in a medical device system
9788822, Sep 25 2003 NuVasive, Inc. Surgical access system and related methods
9795371, Jan 16 2003 NuVasive, Inc. Surgical access system and related methods
9808631, Aug 06 2014 Cardiac Pacemakers, Inc. Communication between a plurality of medical devices using time delays between communication pulses to distinguish between symbols
9820729, Oct 08 2002 NuVasive, Inc. Surgical access system and related methods
9826968, Jun 26 2002 NuVasive, Inc. Surgical access system and related methods
9827109, Mar 07 1999 NuVasive, Inc Methods and apparatus for performing spine surgery
9827420, Mar 29 2013 NEUROMETRIX, INC Transcutaneous electrical nerve stimulator with user gesture detector and electrode-skin contact detector, with transient motion detector for increasing the accuracy of the same
9833227, Jun 26 2002 NuVasive, Inc. Surgical access system and related methods
9848861, Jun 26 2002 NuVasive, Inc. Surgical access system and related methods
9853743, Aug 20 2015 Cardiac Pacemakers, Inc Systems and methods for communication between medical devices
9907514, Jun 01 2015 EMPOWERMENT TECHNOLOGIES INC Monitoring device and system for providing an alert when an infant is unresponsive to stimulus
9931045, Dec 08 2008 Medtronic Xomed, Inc. Nerve electrode
9931077, Jul 11 2001 NuVasive, Inc. System and methods for determining nerve proximity, direction and pathology during surgery
9949840, Apr 01 2011 Systems and methods for performing spine surgery
9956414, Aug 27 2015 Cardiac Pacemakers, Inc.; Cardiac Pacemakers, Inc Temporal configuration of a motion sensor in an implantable medical device
9968787, Aug 27 2015 Cardiac Pacemakers, Inc Spatial configuration of a motion sensor in an implantable medical device
9974489, Jun 01 2015 EMPOWERMENT TECHNOLOGIES INC Monitoring device and system for providing an alert when an infant is unresponsive to stimulus
9974531, Sep 25 2003 NuVasive, Inc. Surgical access system and related methods
9993654, May 18 2005 Cardiac Pacemakers, Inc. Modular antitachyarrhythmia therapy system
D837394, Jul 11 2017 NEUROMETRIX, INC Transcutaneous electrical nerve stimulation (TENS) device
D857910, Sep 21 2017 NEUROMETRIX, INC Transcutaneous electrical nerve stimulation device
D861903, May 15 2018 NEUROMETRIX, INC Apparatus for transcutaneous electrical nerve stimulation
D865986, Sep 21 2017 NEUROMETRIX, INC Transcutaneous electrical nerve stimulation device strap
D949415, Sep 14 2020 Health Bloom, LLC Electrical stimulation device
RE44049, Apr 06 2000 Bipolar handheld nerve locator and evaluator
Patent Priority Assignee Title
3886931,
4807643, Aug 16 1982 University of Iowa Research Foundation Digital electroneurometer
5080099, Aug 26 1988 Conmed Corporation Multi-pad, multi-function electrode
5092344, Nov 19 1990 Remote indicator for stimulator
5131401, Sep 10 1990 AXON MEDICAL INC , A CORP OF UT Method and apparatus for monitoring neuromuscular blockage
5143081, Jul 27 1990 New York University Randomized double pulse stimulus and paired event analysis
5215100, Apr 29 1991 HEALTHSOUTH OCCUPATIONAL AND PREVENTIVE DIAGNOSTICS LIMITED PARTNERSHIP Nerve condition monitoring system and electrode supporting structure
5284154, Apr 14 1992 Brigham and Women's Hospital Apparatus for locating a nerve and for protecting nerves from injury during surgery
5327902, May 14 1993 Apparatus for use in nerve conduction studies
5333618, Jun 30 1993 Portable self-contained instrument for the measurement of nerve resistance of a patient
EP25222,
WO9116001,
////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Dec 01 1998NeuroMetrix, Inc.(assignment on the face of the patent)
Dec 27 1999GONZANI, SHAI N NEUROMETRIX, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0105620554 pdf
Dec 27 1999NEIMARK, MATTHEW A NEUROMETRIX, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0105620554 pdf
Dec 27 1999TURNER, CHRISTOPHER T NEUROMETRIX, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0105620554 pdf
Date Maintenance Fee Events
Oct 29 2004M2551: Payment of Maintenance Fee, 4th Yr, Small Entity.
Jan 26 2009M2552: Payment of Maintenance Fee, 8th Yr, Small Entity.
Aug 29 2012M2553: Payment of Maintenance Fee, 12th Yr, Small Entity.


Date Maintenance Schedule
Jul 24 20044 years fee payment window open
Jan 24 20056 months grace period start (w surcharge)
Jul 24 2005patent expiry (for year 4)
Jul 24 20072 years to revive unintentionally abandoned end. (for year 4)
Jul 24 20088 years fee payment window open
Jan 24 20096 months grace period start (w surcharge)
Jul 24 2009patent expiry (for year 8)
Jul 24 20112 years to revive unintentionally abandoned end. (for year 8)
Jul 24 201212 years fee payment window open
Jan 24 20136 months grace period start (w surcharge)
Jul 24 2013patent expiry (for year 12)
Jul 24 20152 years to revive unintentionally abandoned end. (for year 12)